EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ENACT was filed as Word mark on 03/07/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/27/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018032018 |
| Application date | March 7, 2019 |
| Publication date | May 28, 2019 |
| Entry date | March 27, 2020 |
| Expiration date | March 7, 2029 |
Trademark owner
1801 Augustine Cut-off
19803 Wilmington
US
19803 Wilmington
US
Trademark representatives
Avenue Louise 203
1050 Bruxelles
BE
Objection / Complaint
goods and services
5
Pharmaceuticals and pharmaceutical preparations for human and veterinary use in connection with cancer or oncology; antibodies for human and veterinary use in connection with cancer or oncology; biological substances for human medical diagnostics and analysis for use in connection with cancer or oncology; medical diagnostic reagents for use in connection with cancer or oncology; clinical medical reagents for use in connection with cancer or oncology; Biological preparations for medical and veterinary purposes for use in connection with cancer or oncology
42
Research and development in the pharmaceutical and biotechnology fields in connection with cancer or oncology; research and development of medicines in the fields of cancer or oncology; scientific and technological services and research and design services in the fields of cancer or oncology; biological research, clinical research and medical research in the fields of cancer or oncology; chemical and biochemical analysis services in the fields of cancer or oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer or oncology; clinical research in the fields of cancer or oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer or oncology; Research and development services in the field of antibodies for use in connection with cancer or oncology
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 18, 2024 | Transfer / Change of address, Published | ||
| February 3, 2022 | Change Representative, Published |
ID: 11018032018